133 related articles for article (PubMed ID: 3972798)
1. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
[TBL] [Abstract][Full Text] [Related]
2. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
3. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
Stimler NP; Bach MK; Bloor CM; Hugli TE
J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
[TBL] [Abstract][Full Text] [Related]
4. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
5. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
Zimmermann B; Damerau B; Vogt W
Hoppe Seylers Z Physiol Chem; 1980; 361(6):915-24. PubMed ID: 7399411
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
7. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
8. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
Abdullah NA; Assem ES; Damerau B
Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
[TBL] [Abstract][Full Text] [Related]
9. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
Zimmermann B; Vogt W
Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
Damerau B; Grünefeld E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
[TBL] [Abstract][Full Text] [Related]
11. Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments.
Camussi G; Tetta C; Bussolino F; Cappio FC; Coda R; Masera C; Segoloni G
Int Arch Allergy Appl Immunol; 1980; 62(1):1-15. PubMed ID: 7372359
[TBL] [Abstract][Full Text] [Related]
12. Amino acid sequence of guinea pig C3a anaphylatoxin.
Gerard NP; Lively MO; Gerard C
Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
[TBL] [Abstract][Full Text] [Related]
13. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Fernandez HN; Hugli TE
J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.
Gerard C; Hugli TE
J Biol Chem; 1979 Jul; 254(14):6346-51. PubMed ID: 447720
[No Abstract] [Full Text] [Related]
15. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
16. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
17. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
Scola AM; Higginbottom A; Partridge LJ; Reid RC; Woodruff T; Taylor SM; Fairlie DP; Monk PN
J Biol Chem; 2007 Feb; 282(6):3664-71. PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
18. Biologically active complement (C5)-derived peptides and their relevance to disease.
Perez HD
Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
[TBL] [Abstract][Full Text] [Related]
19. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
20. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L; Carney DF; Hugli TE
Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
